ArticleIn vivo (Athens, Greece)

Long-term Outcomes and Mixed Response in Nivolumab Therapy for Head and Neck Cancer.

Yoh-Ichiro Iwasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.